We are Sorry, This Page doesn't Exist
Arena Pharmaceuticals, Inc. (ARNA) Presents at Evercore HealthCONx Broker Conference Call - (Transcript)
Arena Pharmaceuticals, Inc. (ARNA) Presents at Evercore HealthCONx Broker Conference Call - (Transcript).....»»
AstraZeneca says Imfinzi granted FDA Priority Review, sBLA accepted
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Incyte announces pemigatinib NDA accepted for priority review by FDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TherapeuticsMD, Knight Therapeutics announce Bijuva NDS accepted for review
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: Endo"s Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 0 read more.....»»
Endo announces FDA accepted for review the original BLA for CCH
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs
SAN DIEGO, Nov. 7, 2019 /PRNewswire/ --Â Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today provided a corporate update and reported financial results for the third qu.....»»
Foamix Pharmaceuticals" FDA Application Accepted For Review, Catalyst Laid Out Ahead
Foamix Pharmaceuticals" FDA Application Accepted For Review, Catalyst Laid Out Ahead.....»»
Hedge Funds Have Never Been This Bullish On Arena Pharmaceuticals, Inc. (ARNA)
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest re.....»»
CBF Morning Run: What you need to know today, the shiny new Jackets season and a Friday beer review
Happy Friday morning, Columbus. New year, new model. This evening, my oldest daughter and I will walk into Nationwide Arena and breathe in that new-season smell. Ah. On opening night, everything is bright, shiny, factory-fresh and full of prom.....»»
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 2019 Cantor Global Healthcare Conference (Transcript)
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 2019 Cantor Global Healthcare Conference (Transcript).....»»
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children......»»
Arena Pharmaceuticals is Now Oversold (ARNA)
Dividend Channel.....»»
First Week of December 20th Options Trading For Arena Pharmaceuticals (ARNA)
Stock Options Channel.....»»
Will This Ebola Vaccine Be the Next Big Thing?
NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola vaccine......»»
Arena Pharmaceuticals Inc (ARNA) EVP, General Counsel & Sec Steven W Spector Sold $2. ...
Related Stocks: ARNA,.....»»
Arena Pharmaceuticals Enters Oversold Territory (ARNA)
Dividend Channel.....»»
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2019 Results - Earnings Call Transcript
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2019 Results - Earnings Call Transcript.....»»
Melinta Therapeutics says FDA accepted Baxdela sNDA for priority review
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: Neurocrine"s Parkinson"s Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven"s Migraine Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. read more.....»»